Search Results 541-550 of 17260 for GLP-1 therapy

  1. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    Approximately, up to 140 subjects and 154 subjects will receive study treatment in Phase I and Phase II respectively. A completed subject will be one who is ...

  2. Study Of High-dose Spironolactone Vs. Placebo Therapy In Acute Heart Failure - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  3. A Study To Evaluate Accelerated Resolution Therapy In Cancer And Palliative Care - Mayo Clinic

    The following research questions will guide this study: 1) Is ART feasible and acceptable for use with distressed patients and/or family caregivers in oncology ...

  4. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia - Mayo Clinic

    ... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long-term safety ... Therapy, and a greater proportion of ...

  5. Hyperinsulinemia: Is it diabetes? - Mayo Clinic

    Treatment of hyperinsulinemia is directed at the problem that's causing it. ... Click here for an email preview. Email. Address 1 ... Podcast: How do GLP-1s work?

  6. Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes - Mayo Clinic

    Participants will either get semaglutide or "dummy" medicine, which treatment participants get is decided by chance. Participants will need to take 1 injection ...

  7. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy - Mayo Clinic

    The purpose of this study is to correlate gut microbiome with specific cancer diagnoses and the clinical response (effectiveness), and adverse effects of cancer ...

  8. Publications - Neera Agrwal, M.D., Ph.D. - Mayo Clinic

    Antithrombotic Therapy for Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention. J Am Osteopath Assoc. 2020 May 1 ...

  9. A Study of the Effectiveness and Safety of Subcutaneous Semaglutide for Patients with Fatty-Liver Disease, not Caused by Alcoholism - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  10. Heart valve disease - Doctors and departments - Mayo Clinic

    Heart & Blood Health Discussions. ldjones99 · Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec ...